Diaceutics PLC (AIM:DXRX)

Diaceutics Statistics

Total Valuation

Diaceutics has a market cap or net worth of GBP 115.95 million. The enterprise value is 106.70 million.

Market Cap	115.95M
Enterprise Value	106.70M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Diaceutics has 84.64 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	84.64M
Shares Outstanding	84.64M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	23.42%
Owned by Institutions (%)	48.67%
Float	49.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	52.69
PS Ratio	3.37
PB Ratio	3.11
P/TBV Ratio	5.30
P/FCF Ratio	11,595.31
P/OCF Ratio	1,114.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 69.88, with an EV/FCF ratio of 10,670.31.

EV / Earnings	-70.20
EV / Sales	3.10
EV / EBITDA	69.88
EV / EBIT	n/a
EV / FCF	10,670.31

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.03.

Current Ratio	3.96
Quick Ratio	3.66
Debt / Equity	0.03
Debt / EBITDA	0.74
Debt / FCF	113.40
Interest Coverage	-37.25

Financial Efficiency

Return on equity (ROE) is -4.00% and return on invested capital (ROIC) is -3.27%.

Return on Equity (ROE)	-4.00%
Return on Assets (ROA)	-2.85%
Return on Invested Capital (ROIC)	-3.27%
Return on Capital Employed (ROCE)	-5.36%
Revenue Per Employee	161,512
Profits Per Employee	-7,136
Employee Count	199
Asset Turnover	0.77
Inventory Turnover	n/a

Taxes

Income Tax	-137,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.60% in the last 52 weeks. The beta is 0.95, so Diaceutics's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+17.60%
50-Day Moving Average	159.98
200-Day Moving Average	137.48
Relative Strength Index (RSI)	14.93
Average Volume (20 Days)	88,668

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diaceutics had revenue of GBP 34.40 million and -1.52 million in losses. Loss per share was -0.02.

Revenue	34.40M
Gross Profit	29.63M
Operating Income	-2.05M
Pretax Income	-1.66M
Net Income	-1.52M
EBITDA	1.33M
EBIT	-2.05M
Loss Per Share	-0.02

Balance Sheet

The company has 10.38 million in cash and 1.13 million in debt, giving a net cash position of 9.25 million or 0.11 per share.

Cash & Cash Equivalents	10.38M
Total Debt	1.13M
Net Cash	9.25M
Net Cash Per Share	0.11
Equity (Book Value)	37.24M
Book Value Per Share	0.44
Working Capital	18.28M

Cash Flow

In the last 12 months, operating cash flow was 104,000 and capital expenditures -94,000, giving a free cash flow of 10,000.

Operating Cash Flow	104,000
Capital Expenditures	-94,000
Free Cash Flow	10,000
FCF Per Share	0.00

Margins

Gross margin is 86.12%, with operating and profit margins of -5.96% and -4.42%.

Gross Margin	86.12%
Operating Margin	-5.96%
Pretax Margin	-4.82%
Profit Margin	-4.42%
EBITDA Margin	3.85%
EBIT Margin	-5.96%
FCF Margin	0.03%

Dividends & Yields

Diaceutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	-0.19%
Earnings Yield	-1.31%
FCF Yield	0.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diaceutics has an Altman Z-Score of 11.4 and a Piotroski F-Score of 4.

Altman Z-Score	11.4
Piotroski F-Score	4